AOCI at other companies
Other financials
Where this comes from
Reported directly by Corcept Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax.
The official record: Corcept Therapeutics’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Corcept Therapeutics's aoci.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Corcept Therapeutics's AOCI?
- Corcept Therapeutics (CORT) reported AOCI of $918K in Q1 2026.
- How has Corcept Therapeutics's AOCI changed year-over-year?
- Corcept Therapeutics's AOCI increased by 32.7% year-over-year, from $692K to $918K.
- What is the long-term trend for Corcept Therapeutics's AOCI?
- Over 5 years (2020 to 2025), Corcept Therapeutics's AOCI has grown at a 40.4% compound annual growth rate (CAGR), from $415K to $2.26M.
- What does AOCI mean?
- Cumulative unrealized gains or losses not included in net income.
- How do you interpret AOCI?
- Fluctuations reflect changes in market conditions, interest rates, or currency exchange rates rather than core operational performance.
- How does AOCI compare across companies?
- Varies significantly based on a company's international exposure and investment portfolio.